Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Kythera Biopharmaceuticals
Biotech
Sienna slumps as acne asset flunks phase 3 trials
The addition of the silver particle treatment to laser light therapy failed to improve outcomes against three key endpoints in two trials.
Nick Paul Taylor
Jul 30, 2018 9:21am
JLABS alumnus Sienna guns for $75M IPO months after series B
Jul 6, 2017 4:25am
Ex-Kythera team raises $40M for dermatology clinical trials
Apr 25, 2017 5:04am
Kythera vets regroup around a $34M cosmetic biotech startup
Apr 29, 2016 9:54am